ENZN - Enzon Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue6,9188,3798,31417,258
Cost of Revenue----
Gross Profit6,9188,3798,31417,258
Operating Expenses
Research Development----
Selling General and Administrative1,0631,3711,6792,150
Non Recurring----
Total Operating Expenses1,0631,3711,6161,952
Operating Income or Loss5,8557,0086,69815,306
Income from Continuing Operations
Total Other Income/Expenses Net---54-4,506
Earnings Before Interest and Taxes5,8557,0086,69815,306
Interest Expense----
Income Before Tax5,8557,0086,64410,800
Income Tax Expense61,5637,770-10,837
Minority Interest----
Net Income From Continuing Ops5,8495,445-1,12621,637
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income5,8495,445-1,12621,637
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares5,8495,445-1,12621,637